|
|
Treatment
of Chronic Depression
Patients
with chronic forms of major depression are difficult to treat, and the relative
effectiveness of medications and psychotherapy is uncertain. This study
compared nefazodone, a cognitive behavioral-analysis system of psychotherapy,
and the two in combination for the short-term treatment of 681 adults with
a chronic nonpsychotic major depressive disorder. Over a 12-week period,
they found that although about half the patients had a response to either
nefazodone or psychotherapy alone, the combination of the two was significantly
more effective than either treatment alone.
Discontinuing
Sedation during Mechanical Ventilation
Critically ill patients receiving mechanical
ventilation are often given continuous infusions of sedative and analgesic
drugs. These infusions may make it difficult to evaluate mental status and
to determine when mechanical ventilation can be discontinued. Among 128
patients receiving mechanical ventilation in the intensive care unit, those
in whom sedative infusions were interrupted daily had a shorter duration
of mechanical ventilation and earlier discharge from the intensive care
unit than patients in whom infusions were not interrupted.
Coronary
Calcification in Young Adults on Dialysis
Older adults with end-stage renal disease
treated by dialysis are at high risk for coronary artery disease, but whether
children and young adults with end-stage renal disease are similarly affected
is not known. A cardinal anatomical feature of coronary artery disease is
coronary-artery calcification, which can be detected noninvasively by electron-beam
computed tomography. The authors found that among 39 patients under the
age of 30 with end-stage renal disease treated by dialysis, 36 percent had
coronary-artery calcification, as compared with 5 percent of 60 normal subjects.
Levodopa
or Ropinirole in Early Parkinson's Disease?
Dyskinesia is a troublesome and common side effect of treatment with levodopa.
In this double-blind trial, 268 patients with early Parkinson's disease
were assigned to treatment with either levodopa or ropinirole, a dopamine
agonist. By the end of five years, the rates of dyskinesia were 45 percent
with levodopa and 20 percent with ropinirole. The authors conclude that
early Parkinsonıs disease can be managed with a reduced risk of dyskinesia
by initiating treatment with ropinirole alone and supplementing it with
levodopa if necessary. |